ATAZANAVIR SULPHATE IP/BP/USP/EP

✅ ATAZANAVIR SULPHATE (CAS 229975-97-7) – PRODUCT DESCRIPTION

Atazanavir Sulphate (CAS 229975-97-7) is an antiretroviral medication, a protease inhibitor, used for the treatment of HIV/AIDS. It works by inhibiting the HIV protease enzyme, which is crucial for the maturation of the HIV virus. By preventing viral maturation, Atazanavir reduces the virus's ability to replicate, thereby lowering the viral load and improving immune function in HIV-infected individuals. This yellow to orange crystalline powder is used in combination with other antiretroviral agents in HIV treatment regimens. Atazanavir Sulphate is commonly available in oral tablets and capsules, ensuring effective long-term therapy for HIV patients. We supply Atazanavir Sulphate in pharmaceutical grades (IP/BP/USP/EP) and ensure high-quality standards for reliable distribution globally, including to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (HIV/AIDS treatment, antiretroviral therapy)

• Healthcare (management of HIV and related conditions)

• Research (studies on HIV treatment, antiretroviral drugs)

• Manufacturing (production of oral tablets and capsules for HIV treatment)

🧪 Available Grades:

• Pharmaceutical Grade (IP/BP/USP/EP)

• Reagent Grade

• Laboratory Grade

⚙️ Functions:

• Protease inhibitor used for the treatment of HIV/AIDS

• Prevents viral replication by inhibiting HIV protease enzyme

• Part of combination therapy to reduce HIV viral load and increase immune function

• Effective in treating chronic HIV infection

• Research reagent in HIV-related studies

🧩 Classified Under:

• Pharmaceuticals

• Antiretrovirals

• HIV/AIDS Treatment

• Active Pharmaceutical Ingredients (APIs)

• Protease Inhibitors